Home » Topics » BioWorld Science

BioWorld Science
RSS

Nicox's NCX-470 enters phase III development

June 2, 2020

Mesothelin-targeting CAR MCY-M11 appears to be safe in phase I trial

June 2, 2020

FDA approves Brilinta to reduce first heart attack in patients with coronary artery disease

June 2, 2020

Avelumab does not show activity in recurrent osteosarcoma trial

June 2, 2020

Interim phase Ib data with ALRN-6924 show chemoprotective effect

June 2, 2020

Ocugen discontinues phase III trial of OCU-300 for ocular graft-versus-host disease

June 2, 2020

FDA clears Opko to begin phase II trial of Rayaldee for mild to moderate COVID-19

June 2, 2020

Gilead reports phase III data on remdesivir in moderate COVID-19 pneumonia

June 2, 2020

Novus reports topline phase IIa data on OP-0201 in acute otitis media

June 2, 2020

Genentech and Roche synthesize new RAS protein inhibitors

June 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...